Serum vascular endothelial growth factor receptor-3 levels in patients with esophageal squamous cell cancer.

Aim: Esophageal cancer is one of the most aggressive tumors of the gastrointestinal tract. In this study, we quantified the serum vascular endothelial growth factor-3 (VEGFR-3) expression in patients with esophageal squamous cell carcinoma (ESCC) to evaluate the role of VEGFR-3 in ESCC.

Materials And Methods: Ninety five patients with ESCC were studied.